Compounds > angiotensin ii, des-asp(1)-des-arg(2)-ile(5)-
Page last updated: 2024-09-03

angiotensin ii, des-asp(1)-des-arg(2)-ile(5)- and Prostatic Neoplasms

angiotensin ii, des-asp(1)-des-arg(2)-ile(5)- has been researched along with Prostatic Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dominska, K; Lachowicz-Ochedalska, A; Ochedalski, T; Piastowska-Ciesielska, AW; Pluciennik, E1
Fournie-Zaluski, MC; Juzala, A; Pawlikowski, M; Potocka, AM; Ławnicka, H1

Other Studies

2 other study(ies) available for angiotensin ii, des-asp(1)-des-arg(2)-ile(5)- and Prostatic Neoplasms

ArticleYear
A comparison of the effects of Angiotensin IV on androgen-dependent and androgen-independent prostate cancer cell lines.
    Journal of the renin-angiotensin-aldosterone system : JRAAS, 2013, Volume: 14, Issue:1

    Topics: Androgens; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Cell Line, Tumor; Cell Proliferation; Cell Survival; Humans; Male; Prostatic Neoplasms; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin

2013
Angiotensin II and its fragments (angiotensins III and IV) decrease the growth of DU-145 prostate cancer in vitro.
    Medical science monitor : international medical journal of experimental and clinical research, 2004, Volume: 10, Issue:11

    Topics: Angiotensin II; Angiotensin III; Cell Line, Tumor; Cell Survival; Glutamyl Aminopeptidase; Humans; Male; Prostatic Neoplasms; Sulfonic Acids

2004